 "Cipla hits 52-week low on disappointing Q4 results")
Cipla has dipped 7% to Rs 460, also its 52-week low on the BSE, after the company reported a sharp 69% year-on-year drop in net profit to Rs 81 crore in the quarter ended March 2016 (Q4FY16), on account of one-off expenses related to inventory reduction and closure of business in some small-sized foreign markets.
The drug maker had profit of Rs 260 crore in the same quarter year ago.
Income from operations grew 5.6% to Rs 3,267 crore against Rs 3,093 crore in the corresponding quarter of previous fiscal.
Analysts, on an average, had expected profit of Rs 361 crore on revenues of Rs 3,307 crore.
Till 09:42 am, a combined 4.03 million shares changed hands on the counter on the NSE and BSE.
The drug maker had profit of Rs 260 crore in the same quarter year ago.
Income from operations grew 5.6% to Rs 3,267 crore against Rs 3,093 crore in the corresponding quarter of previous fiscal.
Analysts, on an average, had expected profit of Rs 361 crore on revenues of Rs 3,307 crore.
Till 09:42 am, a combined 4.03 million shares changed hands on the counter on the NSE and BSE.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →*Subscribe to Business Standard digital and get complimentary access to The New York Times
Smart Quarterly
₹900
3 Months
₹300/Month
SAVE 25%
Smart Essential
₹2,700
1 Year
₹225/Month
SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months
Super Saver
₹3,900
2 Years
₹162/Month
Subscribe
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors
Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share
Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor
Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements
Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
SAVE 25%